- Filed
- Apr 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Apr 8, 2025 | 10.98M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 79.42K sh |
| Capex | FY 2024 · Dec 31, 2023 | $14.3K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$40.89M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $5.29M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $10.81M |
| Current Assets | FY 2024 · Dec 31, 2023 | $17.49M |
| Total Assets | FY 2024 · Dec 31, 2023 | $18.09M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$616.07 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$616.07 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $9.62M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $35.64M |
| Net Income | FY 2024 · Dec 31, 2023 | −$48.93M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$48.45M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $49.86M |